MEDIMMUNE

medimmune-logo

MedImmune develops medicines for unmet medical needs worldwide. As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.

#SimilarOrganizations #People #Financial #Website #More

MEDIMMUNE

Social Links:

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
1987-01-01

Address:
Maryland, Louisiana, United States

Country:
United States

Website Url:
http://www.astrazeneca.com

Total Employee:
5001+

Status:
Active

Contact:
301-398-0000

Technology used in webpage:
WordPress Wordpress Plugins IPv6 Microsoft Azure DNS PHP Amazon Route 53 Microsoft Japanese Yen Mimecast GlobalSign Domain Verification


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

bionorica-se-logo

Bionorica SE

Bionorica SE develops and manufactures herbal medicines for customers worldwide.

encysive-pharmaceuticals-logo

Encysive Pharmaceuticals

Encysive Pharmaceuticals develops synthetic and small molecule compounds to address medical needs worldwide.

hylands-logo

Hyland's

Hylandโ€™s, Inc., a division of Standard Homeopathic Company.

ilex-oncologyinc-logo

ILEX Oncology,Inc.

ILEX is a drug development company focused exclusively on oncology.

leica-biosystems-logo

Leica Biosystems

Leica Biosystems develops laboratory workflow solutions for anatomic pathology involved in the advancement of cancer diagnostics.

nexien-biopharma-logo

Nexien BioPharma

Nexien BioPharma develops cannabinoid based medications for specific medical conditions and disorders.

pacylex-logo

Pacylex

Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.

sunlight-logo

Sunlight

Sunlight develops technology that improves people's working lives.

viramatix-logo

Viramatix

We develop therapeutics for viral diseases of unmet medical need.

Current Employees Featured

rakesh-dixit_image

Rakesh Dixit
Rakesh Dixit Vice President, R & D, Global Head, Biologics Safety Assessment @ MedImmune
Vice President, R & D, Global Head, Biologics Safety Assessment

ed-mathers_image

Ed Mathers
Ed Mathers Executive Vice President, Corporate Development and Venture @ MedImmune
Executive Vice President, Corporate Development and Venture

frank-j-malinoski_image

Frank J. Malinoski
Frank J. Malinoski Team Member @ MedImmune
Team Member

cristina-rondinone_image

Cristina Rondinone
Cristina Rondinone Senior Vice President, Head Of Cardiovascular, Renal and Metabolic Diseases @ MedImmune
Senior Vice President, Head Of Cardiovascular, Renal and Metabolic Diseases
2019-01-01

not_available_image

Jhi Zhu
Jhi Zhu Senior Scientist @ MedImmune
Senior Scientist

james-brown_image

James Brown
James Brown Director, IT Relationship Management, R&D @ MedImmune
Director, IT Relationship Management, R&D
2007-05-01

not_available_image

Michael Dittmer
Michael Dittmer Associate Scientist, BioProcess Engineering @ MedImmune
Associate Scientist, BioProcess Engineering

Founder


wayne-hockmeyer_image

Wayne Hockmeyer

Acquisitions List

Date Company Article Price
2014-11-04 Definiens Definiens acquired by MedImmune 150 M USD
2014-09-19 Allozyne Allozyne acquired by MedImmune 5.5 M USD
2013-10-15 Spirogen Spirogen acquired by MedImmune 440 M USD
2013-08-27 Amplimmune Amplimmune acquired by MedImmune 500 M USD
2013-04-03 AlphaCore Pharma AlphaCore Pharma acquired by MedImmune N/A
2005-09-15 Cellective Therapeutics Cellective Therapeutics acquired by MedImmune 160 M USD

Investments List

Date Company Article Money raised
2018-04-25 Corvidia MedImmune investment in Series B - Corvidia 60 M USD
2014-11-10 MdBio Foundation MedImmune investment in Grant - MdBio Foundation 500 K USD
2013-10-16 ADC Therapeutics MedImmune investment in Series B - ADC Therapeutics 40 M USD

Official Site Inspections

http://www.astrazeneca.com Semrush global rank: 3.13 M Semrush visits lastest month: 1.69 K

  • Host name: ac9efcde36061855b.awsglobalaccelerator.com
  • IP address: 15.197.255.153
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "MedImmune" on Search Engine